Winthrop Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Buy
7,610
+20
+0.3% +$4.66K 0.47% 45
2026
Q1
$1.85M Buy
7,590
+136
+2% +$31.7K 0.48% 43
2025
Q4
$1.54M Sell
7,454
-1,079
-13% -$213K 0.36% 56
2025
Q3
$1.58M Buy
8,533
+309
+4% +$52.9K 0.38% 52
2025
Q2
$1.26M Sell
8,224
-1,801
-18% -$277K 0.32% 63
2025
Q1
$1.66M Buy
10,025
+237
+2% +$37.1K 0.46% 46
2024
Q4
$1.4M Buy
+9,788
New +$1.52M 0.37% 57
2024
Q3
Sell
-9,331
Closed -$1.36M 169
2024
Q2
$1.36M Buy
9,331
+5
+0.1% +$744 0.68% 28
2024
Q1
$1.48M Buy
9,326
+76
+0.8% +$12.1K 0.68% 28
2023
Q4
$1.45M Buy
+9,250
New +$1.42M 0.47% 45

Other funds holding JNJ

Winthrop Capital Management's JNJ Position: Q2 2026 in Review

Winthrop Capital Management increased its Johnson & Johnson (JNJ) stake by 0.26% in Q2 2026, buying an estimated $4.66K and bringing the position to 7,610 shares worth $1.93M. The position accounts for 0.47% of the portfolio, ranked #45.

Winthrop Capital Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,691 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Winthrop Capital Management held 7,610 shares of Johnson & Johnson worth $1.93M as of Q2 2026.
  • Winthrop Capital Management bought 20 Johnson & Johnson shares in Q2 2026, an estimated $4.66K.
  • Johnson & Johnson made up 0.47% of Winthrop Capital Management's portfolio in Q2 2026, its #45 holding.
  • Winthrop Capital Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,691 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.